Microbiology Spectrum · 2023 · 33 citations · 43 references
Life SciencesCancer BiologyMicrobiologyAutophagyMicrobial EcologyMicrobiome ResearchColorectal CancerGut HealthGut MicrobiomeGut MicrobiotaMicrobiome CompositionMicrobiome FunctionAutophagy ImpairmentAutophagy PathwayFusobacterium SpeciesGut Microbiota EffectsHost-microbiome Interactions In CancerIntestinal Microbiota EffectsIntestinal Microbiota ModulationMicrobiome-associated Metabolites
ABSTRACT Fusobacterium nucleatum is a harmful bacterium that produces hydrogen sulfide by metabolizing sulfur-containing amino acids, both of which have been shown to promote/initiate the development of various cancers, such as colorectal cancer, liver cancer, as well as lung cancer. However, few studies have reported how F. nucleatum acts on gut microbiota, influences the autophagy process, and promotes the development of colorectal cancer through the metabolite hydrogen sulfide. It was found that HCT116 cells secreted more inflammatory factors and showed higher survival as well as migration rate when given a pathological concentration of hydrogen sulfide. Using cellular transcriptome sequencing, it could be seen that after giving HCT116 cells F. nucleatum or F. nucleatum with L-cysteine, many inflammation-related signaling pathways, including autophagic pathways, were elevated compared to the control group. In vivo , the mice in the model groups displayed cancer progression, and the expression of some of the autophagy-related genes, DRAM1 , NBR1 , ATG7 , MAP1LC3A were also increased in mice given F. nucleatum or F. nucleatum with L-cysteine when compared to the untreated control mice. The number of certain probiotic bacteria and fungi in the mice given F. nucleatum or F. nucleatum and L-cysteine decreased significantly; in contrast, the number of potentially pathogenic bacteria and fungi increased. These findings suggest that F. nucleatum and its metabolite hydrogen sulfide can modulate intestinal microbiota and autophagy as well as promote the development and progression of colorectal cancer. IMPORTANCE Colorectal cancer (CRC) is the second most common cancer in the world; the main treatment for CRC is immunosuppressive therapy, but this therapy is only effective for a small percentage of CRC patients, so there is an urgent need for a treatment with fewer side effects and higher efficacy. This study demonstrated that Fusobacterium nucleatum with increased abundance in CRC can regulate the autophagy process and disrupt normal intestinal microbiota by producing hydrogen sulfide, factors that may be involved in the development and progression of CRC. This study may provide a reference for future CRC treatment options that are efficient and have fewer side effects.
43
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Ta-Chung Yu, Fangfang Guo, Yanan Yu et al. · Cell · 2017 · 2.2K citations · Full text
Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults
Tiffany L. Weir, Daniel K. Manter, Amy M. Sheflin et al. · PLoS ONE · 2013 · 665 citations · Full text
Evidence That Hydrogen Sulfide Is a Genotoxic Agent
Matias S. Attene‐Ramos, Elizabeth D. Wagner, Michael J. Plewa et al. · Molecular Cancer Research · 2006 · 361 citations · Full text
Pharmacy, Microbiology, Toxicology +17
Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer
Yaohui Gao, Dexi Bi, Ruting Xie et al. · Signal Transduction and Targeted Therapy · 2021 · 283 citations · Full text
Life Sciences, Immunology, Oncology +17